Source:http://linkedlifedata.com/resource/pubmed/id/16468490
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2006-2-10
|
pubmed:abstractText |
This retrospective review evaluates the effectiveness and tolerability of hylan G-F 20 for relief of pain due to knee osteoarthritis in a large orthopedic practice over a 5-year period. Prospectively collected data from patients who initiated intra-articular hylan G-F 20 (3 weekly injections) for osteoarthritis knee pain treatment were analyzed. Efficacy variables included physician visual analogue scale (VAS: 100 mm), and patient rating of pain, mobility, and amount of pain medication taken after treatment. Patients (n=1047; 1489 knees) were an average age of 65.3 years, 60% female, and 71% had radiologic osteoarthritis grade IV. Mean VAS scores significantly improved with hylan G-F 20 compared to baseline at all time points (P<.0001). Most knees (62%-89%) responded positively with hylan G-F 20. Pain and mobility improved and less pain medication was needed after therapy. The incidences of local adverse events were 5.2% per patient and 1.2% per injection; most local adverse events were mild or moderate, with severe local events in 0.3% of injections. Our clinical experience shows that hylan G-F 20 effectively relieves osteoarthritis knee pain (as indicated) and reduces pain medication needed for up to 6 months with a low incidence of local adverse events.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1538-8506
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
19-27
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16468490-Adjuvants, Immunologic,
pubmed-meshheading:16468490-Aged,
pubmed-meshheading:16468490-Female,
pubmed-meshheading:16468490-Humans,
pubmed-meshheading:16468490-Hyaluronic Acid,
pubmed-meshheading:16468490-Injections, Intra-Articular,
pubmed-meshheading:16468490-Male,
pubmed-meshheading:16468490-Osteoarthritis, Knee,
pubmed-meshheading:16468490-Pain Measurement,
pubmed-meshheading:16468490-Prospective Studies,
pubmed-meshheading:16468490-Retrospective Studies,
pubmed-meshheading:16468490-Severity of Illness Index,
pubmed-meshheading:16468490-Treatment Outcome
|
pubmed:year |
2006
|
pubmed:articleTitle |
Clinical experience with the effectiveness and tolerability of hylan G-F 20 in 1047 patients with osteoarthritis of the knee.
|
pubmed:affiliation |
Orthopedic Specialists of Louisiana, Shreveport 71103, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|